Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review.
Aerosols
Air Microbiology
Betacoronavirus
COVID-19
Cardiopulmonary Resuscitation
/ adverse effects
Coronavirus Infections
/ physiopathology
Exhalation
/ physiology
Health Personnel
Humans
Infection Control
/ methods
Infectious Disease Transmission, Patient-to-Professional
/ prevention & control
Masks
Nebulizers and Vaporizers
Pandemics
/ prevention & control
Particle Size
Pneumonia, Viral
/ physiopathology
Respiratory Physiological Phenomena
SARS-CoV-2
COVID-19
SARS-CoV-2
aerosol
airborne
transmission
Journal
Anaesthesia
ISSN: 1365-2044
Titre abrégé: Anaesthesia
Pays: England
ID NLM: 0370524
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
accepted:
16
04
2020
pubmed:
21
4
2020
medline:
25
7
2020
entrez:
21
4
2020
Statut:
ppublish
Résumé
Healthcare workers are at risk of infection during the severe acute respiratory syndrome coronavirus-2 pandemic. International guidance suggests direct droplet transmission is likely and airborne transmission occurs only with aerosol-generating procedures. Recommendations determining infection control measures to ensure healthcare worker safety follow these presumptions. Three mechanisms have been described for the production of smaller sized respiratory particles ('aerosols') that, if inhaled, can deposit in the distal airways. These include: laryngeal activity such as talking and coughing; high velocity gas flow; and cyclical opening and closure of terminal airways. Sneezing and coughing are effective aerosol generators, but all forms of expiration produce particles across a range of sizes. The 5-μm diameter threshold used to differentiate droplet from airborne is an over-simplification of multiple complex, poorly understood biological and physical variables. The evidence defining aerosol-generating procedures comes largely from low-quality case and cohort studies where the exact mode of transmission is unknown as aerosol production was never quantified. We propose that transmission is associated with time in proximity to severe acute respiratory syndrome coronavirus-1 patients with respiratory symptoms, rather than the procedures per se. There is no proven relation between any aerosol-generating procedure with airborne viral content with the exception of bronchoscopy and suctioning. The mechanism for severe acute respiratory syndrome coronavirus-2 transmission is unknown but the evidence suggestive of airborne spread is growing. We speculate that infected patients who cough, have high work of breathing, increased closing capacity and altered respiratory tract lining fluid will be significant producers of pathogenic aerosols. We suggest several aerosol-generating procedures may in fact result in less pathogen aerosolisation than a dyspnoeic and coughing patient. Healthcare workers should appraise the current evidence regarding transmission and apply this to the local infection prevalence. Measures to mitigate airborne transmission should be employed at times of risk. However, the mechanisms and risk factors for transmission are largely unconfirmed. Whilst awaiting robust evidence, a precautionary approach should be considered to assure healthcare worker safety.
Identifiants
pubmed: 32311771
doi: 10.1111/anae.15093
pmc: PMC7264768
doi:
Substances chimiques
Aerosols
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1086-1095Informations de copyright
© 2020 Association of Anaesthetists.
Références
Emerg Infect Dis. 2006 Nov;12(11):1657-62
pubmed: 17283614
Emerg Infect Dis. 2004 Feb;10(2):287-93
pubmed: 15030699
J Virol. 2014 Jul;88(14):7692-5
pubmed: 24789791
Clin Infect Dis. 2017 Oct 15;65(8):1335-1341
pubmed: 29017249
Eur Respir J. 2019 Apr 11;53(4):
pubmed: 30705129
N Engl J Med. 2004 Apr 22;350(17):1731-9
pubmed: 15102999
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
PLoS One. 2013;8(2):e56278
pubmed: 23418548
Am J Respir Crit Care Med. 2004 Jun 1;169(11):1198-202
pubmed: 14990393
Int J Oral Sci. 2020 Feb 24;12(1):8
pubmed: 32094336
J Infect Dis. 2018 Jul 24;218(5):739-747
pubmed: 29878137
Anaesthesia. 2020 Jun;75(6):785-799
pubmed: 32221970
Ann Intensive Care. 2020 Mar 30;10(1):37
pubmed: 32232685
J Infect Dis. 1986 Oct;154(4):709-11
pubmed: 3745978
Emerg Infect Dis. 2004 Feb;10(2):251-5
pubmed: 15030692
Med Eng Phys. 2017 Jun;44:25-31
pubmed: 28373015
Indoor Air. 2007 Jun;17(3):211-25
pubmed: 17542834
Clin Infect Dis. 2009 Feb 15;48(4):438-40
pubmed: 19133798
J Clin Invest. 1969 Mar;48(3):564-73
pubmed: 5773092
Proc Soc Exp Biol Med. 1966 Jul;122(3):800-4
pubmed: 5918954
Curr Opin Crit Care. 2020 Feb;26(1):59-65
pubmed: 31815775
Am J Infect Control. 2016 Sep 2;44(9 Suppl):S102-8
pubmed: 27590694
J Hyg (Lond). 1946 Sep;44(6):471-9
pubmed: 20475760
Intensive Care Med. 2020 Apr;46(4):586-590
pubmed: 32125455
J Occup Environ Hyg. 2015;12(2):107-13
pubmed: 25523206
PLoS Pathog. 2013 Mar;9(3):e1003205
pubmed: 23505369
Chest. 2004 Sep;126(3):845-50
pubmed: 15364765
J Hosp Infect. 2015 Apr;89(4):225-8
pubmed: 25578684
J R Soc Interface. 2011 Aug 7;8(61):1176-84
pubmed: 21300628
Nat Commun. 2013;4:1935
pubmed: 23736803
Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17383-8
pubmed: 15583121
Anaesthesia. 2020 Jul;75(7):843-847
pubmed: 32246843
JAMA. 2020 May 12;323(18):1837-1838
pubmed: 32215590
Emerg Infect Dis. 2004 Feb;10(2):244-8
pubmed: 15030690
Hong Kong Med J. 2014 Aug;20 Suppl 4:9-13
pubmed: 25224111
Emerg Infect Dis. 2004 Feb;10(2):280-6
pubmed: 15030698
Gastroenterology. 2020 May;158(6):1518-1519
pubmed: 32142785
JAMA. 2020 Apr 28;323(16):1610-1612
pubmed: 32129805
J Appl Physiol (1985). 2003 Jul;95(1):348-56
pubmed: 12651864
J Aerosol Med. 1997 Summer;10(2):105-16
pubmed: 10168531
Emerg Infect Dis. 2004 Feb;10(2):269-76
pubmed: 15030696
PLoS One. 2012;7(4):e35797
pubmed: 22563403
J Appl Physiol (1985). 2010 Mar;108(3):584-8
pubmed: 20056850
Clin Chem. 2012 Feb;58(2):431-40
pubmed: 22156667
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
J Occup Environ Hyg. 2012;9(7):443-9
pubmed: 22651099
J Infect. 2011 Jan;62(1):1-13
pubmed: 21094184
Respir Res. 2019 Jan 11;20(1):8
pubmed: 30634967
J Infect Dis. 2005 May 1;191(9):1472-7
pubmed: 15809906